Ambient particulate matter induces an exacerbation of airway inflammation in experimental asthma: Role of interleukin-33

Clinical and Experimental Immunology

Volumn 177, Issue 2, 2014, Pages 491-499

  Shadie, A M ^a   Herbert, C ^a   Kumar, R K ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Airborne pollutants; Asthma exacerbation; Interleukin 33

Indexed keywords

CARBON; INTERLEUKIN 33; INTERLEUKIN 4; MESSENGER RNA; MONOCLONAL ANTIBODY; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; EXPERIMENTAL ASTHMA; FEMALE; LUNG LAVAGE; MOUSE; NONHUMAN; PARTICULATE MATTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION;

AIRBORNE POLLUTANTS; ASTHMA EXACERBATION; INTERLEUKIN-33;

ALLERGENS; ANIMALS; ANTIBODIES, MONOCLONAL; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION; INTERLEUKIN-4; INTERLEUKINS; MICE; OVALBUMIN; PARTICULATE MATTER;

EID: 84904012032     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12348     Document Type: Article

References (50)

1. Kumar RK, Jeffery PK. Pathology of asthma. In: Adkinson NF, Bochner BS, Burks W etal., eds. Middleton's allergy, 8th edn. Cambridge: Elsevier, 2013:986-999.
2. Bahadori K, Doyle-Waters MM, Marra C etal. Economic burden of asthma: a systematic review. BMC Pulm Med 2009; 9:24.
3. Rodrigo GJ, Rodrigo C, Hall JB. Acute asthma in adults: a review. Chest 2004; 125:1081-1102.
4. Dougherty RH, Fahy JV. Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype. Clin Exp Allergy 2009; 39:193-202.
5. Murray CS, Simpson A, Custovic A. Allergens, viruses, and asthma exacerbations. Proc Am Thorac Soc 2004; 1:99-104.
6. Jackson DJ, Sykes A, Mallia P, Johnston SL. Asthma exacerbations: origin, effect, and prevention. J Allergy Clin Immunol 2011; 128:1165-1174.
7. Schwartz J, Slater D, Larson TV, Pierson WE, Koenig JQ. Particulate air pollution and hospital emergency room visits for asthma in Seattle. Am Rev Respir Dis 1993; 147:826-831.
8. Pereira G, Cook A, De Vos AJ, Holman CD. A case-crossover analysis of traffic-related air pollution and emergency department presentations for asthma in Perth, Western Australia. Med J Aust 2010; 193:511-514.
9. Weinmayr G, Romeo E, De Sario M, Weiland SK, Forastiere F. Short-term effects of PM10 and NO2 on respiratory health among children with asthma or asthma-like symptoms: a systematic review and meta-analysis. Environ Health Perspect 2010; 118:449-457.
10. Spira-Cohen A, Chen LC, Kendall M, Lall R, Thurston GD. Personal exposures to traffic-related air pollution and acute respiratory health among Bronx schoolchildren with asthma. Environ Health Perspect 2011; 119:559-565.
11. Anderson JO, Thundiyil JG, Stolbach A. Clearing the air: a review of the effects of particulate matter air pollution on human health. J Med Toxicol 2012; 8:166-175.
12. Takano H, Yoshikawa T, Ichinose T, Miyabara Y, Imaoka K, Sagai M. Diesel exhaust particles enhance antigen-induced airway inflammation and local cytokine expression in mice. Am J Respir Crit Care Med 1997; 156:36-42.
13. Hashimoto S, Gon Y, Takeshita I etal. Diesel exhaust particles activate p38 MAP kinase to produce interleukin 8 and RANTES by human bronchial epithelial cells and N-acetylcysteine attenuates p38 MAP kinase activation. Am J Respir Crit Care Med 2000; 161:280-285.
14. Li N, Wang M, Oberley TD, Sempf JM, Nel AE. Comparison of the pro-oxidative and proinflammatory effects of organic diesel exhaust particle chemicals in bronchial epithelial cells and macrophages. J Immunol 2002; 169:4531-4541.
15. Bleck B, Tse DB, Gordon T, Ahsan MR, Reibman J. Diesel exhaust particle-treated human bronchial epithelial cells upregulate Jagged-1 and OX40 ligand in myeloid dendritic cells via thymic stromal lymphopoietin. J Immunol 2010; 185:6636-6645.
16. Takahashi G, Tanaka H, Wakahara K etal. Effect of diesel exhaust particles on house dust mite-induced airway eosinophilic inflammation and remodeling in mice. J Pharmacol Sci 2010; 112:192-202.
17. Kim J, Natarajan S, Vaickus LJ etal. Diesel exhaust particulates exacerbate asthma-like inflammation by increasing CXC chemokines. Am J Pathol 2011; 179:2730-2739.
18. Watson JG, Chow JC. Clear sky visibility as a challenge for society. Ann Rev Energy Environ 1994; 19:241-266.
19. Yamada E, Funoki S, Abe Y, Umemura S, Yamaguchi D, Fuse Y. Size distribution and characteristics of chemical components in ambient particulate matter. Anal Sci 2005; 21:89-94.
20. Lighty JS, Veranth JM, Sarofim AF. Combustion aerosols: factors governing their size and composition and implications to human health. J Air Waste Manag Assoc 2000; 50:1565-1618.
21. Becker S, Mundandhara S, Devlin RB, Madden M. Regulation of cytokine production in human alveolar macrophages and airway epithelial cells in response to ambient air pollution particles: further mechanistic studies. Toxicol Appl Pharmacol 2005; 207:S269-275.
22. Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998; 53:849-856.
23. Siegle JS, Hansbro N, Herbert C, Yang M, Foster PS, Kumar RK. Airway hyperreactivity in exacerbation of chronic asthma is independent of eosinophilic inflammation. Am J Respir Cell Mol Biol 2006; 35:565-570.
24. Herbert C, Siegle JS, Shadie AM etal. Development of asthmatic inflammation in mice following early-life exposure to ambient environmental particulates and chronic allergen challenge. Dis Model Mech 2013; 6:479-488.
25. Herbert C, Scott MM, Scruton KH etal. Alveolar macrophages stimulate enhanced cytokine production by pulmonary CD4+ T-lymphocytes in an exacerbation of murine chronic asthma. Am J Pathol 2010; 177:1657-1664.
26. Schneider T, Issekutz AC. Quantitation of eosinophil and neutrophil infiltration into rat lung by specific assays for eosinophil peroxidase and myeloperoxidase. Application in a Brown Norway rat model of allergic pulmonary inflammation. J Immunol Methods 1996; 198:1-14.
27. Herbert C, Hettiaratchi A, Webb DC, Thomas PS, Foster PS, Kumar RK. Suppression of cytokine expression by roflumilast and dexamethasone in a mouse model of chronic asthma. Clin Exp Allergy 2008; 38:847-856.
28. Ohno T, Oboki K, Morita H etal. Paracrine IL-33 stimulation enhances lipopolysaccharide-mediated macrophage activation. PLOS ONE 2011; 6:e18404.
29. Kumar RK, Herbert C, Webb DC, Li L, Foster PS. Effects of anticytokine therapy in a mouse model of chronic asthma. Am J Respir Crit Care Med 2004; 170:1043-1048.
30. Laumbach RJ, Kipen HM. Respiratory health effects of air pollution: update on biomass smoke and traffic pollution. J Allergy Clin Immunol 2012; 129:3-11.
31. Provoost S, Maes T, Willart MA, Joos GF, Lambrecht BN, Tournoy KG. Diesel exhaust particles stimulate adaptive immunity by acting on pulmonary dendritic cells. J Immunol 2010; 184:426-432.
32. Reynolds PR, Wasley KM, Allison CH. Diesel particulate matter induces receptor for advanced glycation end-products (RAGE) expression in pulmonary epithelial cells, and RAGE signaling influences NF-kappaB-mediated inflammation. Environ Health Perspect 2011; 119:332-336.
33. Fulkerson PC, Rothenberg ME, Hogan SP. Building a better mouse model: experimental models of chronic asthma. Clin Exp Allergy 2005; 35:1251-1253.
34. Becker S, Soukup JM, Gilmour MI, Devlin RB. Stimulation of human and rat alveolar macrophages by urban air particulates: effects on oxidant radical generation and cytokine production. Toxicol Appl Pharmacol 1996; 141:637-648.
35. Chan JK, Kodani SD, Charrier JG etal. Age-specific effects on rat lung glutathione and antioxidant enzymes after inhaling ultrafine soot. Am J Respir Cell Mol Biol 2013; 48:114-124.
36. Schmitz J, Owyang A, Oldham E etal. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23:479-490.
37. Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 2010; 10:103-110.
38. Liu X, Li M, Wu Y, Zhou Y, Zeng L, Huang T. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochem Biophys Res Commun 2009; 386:181-185.
39. Kurowska-Stolarska M, Stolarski B, Kewin P etal. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol 2009; 183:6469-6477.
40. Prefontaine D, Nadigel J, Chouiali F etal. Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol 2010; 125:752-754.
41. Kurokawa M, Matsukura S, Kawaguchi M etal. Expression and effects of IL-33 and ST2 in allergic bronchial asthma: IL-33 induces eotaxin production in lung fibroblasts. Int Arch Allergy Immunol 2011; 155 (Suppl. 1):12-20.
42. Mizutani N, Nabe T, Yoshino S. IL-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodeling in mice. Immunology 2013; 139:205-218.
43. Kouzaki H, Iijima K, Kobayashi T, O'Grady SM, Kita H. The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. J Immunol 2011; 186:4375-4387.
44. Sabroe I, Parker LC, Dockrell DH, Davies DE, Dower SK, Whyte MK. Targeting the networks that underpin contiguous immunity in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175:306-311.
45. Subrata LS, Bizzintino J, Mamessier E etal. Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children. J Immunol 2009; 183:2793-2800.
46. Bunting MM, Shadie AM, Flesher RP etal. Interleukin-33 drives activation of alveolar macrophages and airway inflammation in a mouse model of acute exacerbation of chronic asthma. Biomed Res Int 2013; 2013:250938.
47. Shoenfelt J, Mitkus RJ, Zeisler R etal. Involvement of TLR2 and TLR4 in inflammatory immune responses induced by fine and coarse ambient air particulate matter. J Leukoc Biol 2009; 86:303-312.
48. Klein Wolterink RG, Kleinjan A, van Nimwegen M etal. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur J Immunol 2012; 42:1106-1116.
49. Barlow JL, Bellosi A, Hardman CS etal. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J Allergy Clin Immunol 2012; 129:191-198.
50. Barlow JL, Peel S, Fox J etal. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J Allergy Clin Immunol 2013; 132:933-941.